docetaxel anhydrous has been researched along with propofol in 3 studies
| Studies (docetaxel anhydrous) | Trials (docetaxel anhydrous) | Recent Studies (post-2010) (docetaxel anhydrous) | Studies (propofol) | Trials (propofol) | Recent Studies (post-2010) (propofol) |
|---|---|---|---|---|---|
| 12,110 | 3,216 | 6,920 | 16,827 | 5,188 | 6,805 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Benzonana, LL; Bevan, C; Brown, R; Huang, H; Ma, D; Perry, NJ; Watts, HR; Zhao, H | 1 |
| Chen, N; Chen, W; Qian, J; Shen, S | 1 |
1 review(s) available for docetaxel anhydrous and propofol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for docetaxel anhydrous and propofol
| Article | Year |
|---|---|
Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination.
Topics: Anesthetics, Inhalation; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isoflurane; Male; Neoplasm Invasiveness; Phosphorylation; Propofol; Prostatic Neoplasms; Protein Processing, Post-Translational; Protein Transport; Taxoids; Up-Regulation; Vascular Endothelial Growth Factor A | 2014 |
Propofol Reversed Hypoxia-Induced Docetaxel Resistance in Prostate Cancer Cells by Preventing Epithelial-Mesenchymal Transition by Inhibiting Hypoxia-Inducible Factor 1
Topics: Cadherins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Docetaxel; Drug Resistance, Neoplasm; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Propofol; Prostate; Prostatic Neoplasms; Signal Transduction; Taxoids; Vimentin | 2018 |